P

Inventor

SATOH YOSHITAKA

US56 patents
⚠️ This page may combine multiple inventors who share the name “SATOH YOSHITAKA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SIGNAL PHARM LLC

18 patents
US7129242B2Oct 31, 2006

Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto

SIGNAL PHARM LLC59 citations96
US9701643B2Jul 11, 2017

Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith

SIGNAL PHARM LLC19 citations91
US7723340B2May 25, 2010

Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith

SIGNAL PHARM LLC46 citations91
US7521446B2Apr 21, 2009

Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith

SIGNAL PHARM LLC39 citations91
US7220771B2May 22, 2007

Methods of using indazole derivatives as JNK inhibitors

SIGNAL PHARM LLC22 citations91
US7211594B2May 1, 2007

Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith

SIGNAL PHARM LLC23 citations91
US7208513B2Apr 24, 2007

Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith

SIGNAL PHARM LLC16 citations91
US7122544B2Oct 17, 2006

Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto

SIGNAL PHARM LLC20 citations90
US9187479B2Nov 17, 2015

Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith

SIGNAL PHARM LLC17 citations89
US7429599B2Sep 30, 2008

Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK

SIGNAL PHARM LLC12 citations84
US10919865B2Feb 16, 2021

Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith

SIGNAL PHARM LLC3 citations83
US10266500B2Apr 23, 2019

Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith

SIGNAL PHARM LLC5 citations83
US10040770B2Aug 7, 2018

Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith

SIGNAL PHARM LLC7 citations83
US7442699B2Oct 28, 2008

Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto

SIGNAL PHARM LLC10 citations82
US7119114B1Oct 10, 2006

Pyrazoloanthrone and derivatives thereof as JNK inhibitors and compositions and methods related thereto

SIGNAL PHARM LLC16 citations81
US9725450B2Aug 8, 2017

Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith

SIGNAL PHARM LLC9 citations80
US11325890B2May 10, 2022

Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith

SIGNAL PHARM LLC2 citations72
US12129237B2Oct 29, 2024

Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith

SIGNAL PHARM LLC0 citations61

ZEON CORP

8 patents

FUTABA DENSHI KOGYO KK

5 patents

DENSO CORP

4 patents

ARRAY BIOPHARMA INC

3 patents

CIBA GEIGY CORP

2 patents

DAINIPPON INK & CHEMICALS

2 patents

BENNETT BRYDON L

1 patent

SIGNAL PHARM INC

1 patent

ALBERS RONALD J

1 patent

BAHMANYAR SOGOLE

1 patent

NISSHIN FLOUR MILLING CO

1 patent

KUBOTA LTD

1 patent

IKEDA TAKEO

1 patent

FUTABA DENSHI KOGYA K K

1 patent

Showing the top 50 of 56 patents by PatentIndex Score.